Pediatric liver tumor(hepatoblastoma, HCN-NOS, hepatocellular carcinoma)
Conditions
Interventions
None listed
Sponsors
pediatric liver tumor committee of Japan Children's Cancer Group
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosed or suspected primary childhood liver tumor (hepatoblastoma, HCN-NOS, hepatocellular carcinoma) 2. Age at diagnosis is less than 18 years 3. Written informed consent has been obtained from the patient or a surrogate 4. Informed consent has been obtained for central pathological review and genetic analysis in an observational study of pediatric solid tumors 5. Plasma (serum) samples can be collected before, during and after treatment 6. Clinical, imaging and pathological findings can be collected at diagnosis, during and after treatment
Exclusion criteria
Exclusion criteria: If the physicians at each facility determine that participation of patient in the study is not appropriate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of days between submission of tumour specimens for molecular genetic analysis (biomarker analysis) and obtain of results of methylation analysis tested by ddPCR method (turnaround time; TAT). | — |
Countries
Japan
Contacts
Public ContactJunya Fujimura
Juntendo university Department of pediatrics
Outcome results
None listed